Yale University, Yale Cancer Center is a clinical research site located in New Haven, Connecticut, United States 06520.
Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.
Yale University, Yale Cancer Center has participated in 26 clinical trials with 14 currently active.
Therapeutic areas: Relapsed or Refractory Peripheral T-Cell Lymphoma, Small Cell Lung Cancer, Non Small Cell Lung Cancer.
Sponsors: Kura Oncology, Inc., Yale University, SystImmune Inc..
Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Yale University, Yale Cancer Center has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Yale University, Yale Cancer Center has 26 clinical trials on record, with 14 currently active. Their work covers Relapsed or Refractory Peripheral T-Cell Lymphoma, Small Cell Lung Cancer, Non Small Cell Lung Cancer.
Yes — Yale University, Yale Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.